图书馆订阅: Guest
Begell Digital Portal Begell 数字图书馆 电子图书 期刊 参考文献及会议录 研究收集
神经生物学评论综述™

ISSN 打印: 0892-0915
ISSN 在线: 2375-0014

Archives: Volume 10, 1996 to Volume 20, 2008

神经生物学评论综述™

DOI: 10.1615/CritRevNeurobiol.v19.i2-3.20
pages 79-118

Psychiatric Implications of Hepatitis-C Infection

Brian Giunta
Department of Psychiatry and Behavioral Medicine, Institute for Research in Psychiatry Neuroimmunology Laboratory, University of South Florida College of Medicine, Tampa, FL 33613
Charurut Somboonwit
Department of Internal Medicine, Division of Infectious Disease and International Medicine, University of South Florida, Tampa, FL 33613
William V. Nikolic
Department of Psychiatry and Behavioral Medicine, Institute for Research in Psychiatry Neuroimmunology Laboratory, University of South Florida College of Medicine, Tampa, FL 33613
Elona Rrapo
Department of Psychiatry and Behavioral Medicine, Institute for Research in Psychiatry Neuroimmunology Laboratory, University of South Florida College of Medicine, Tampa, FL 33613
Jun Tan
Department of Psychiatry and Behavioral Medicine, Institute for Research in Psychiatry Neuroimmunology Laboratory, University of South Florida College of Medicine, Tampa, FL 33613
Paul Shapshak
Department of Psychiatry and Behavioral Medicine, Institute for Research in Psychiatry Neuroimmunology Laboratory, University of South Florida College of Medicine, Tampa, FL 33613
Francisco Fernandez
Department of Psychiatry and Behavioral Medicine, Institute for Research in Psychiatry Neuroimmunology Laboratory, University of South Florida College of Medicine, Tampa, FL 33613

ABSTRACT

Hepatitis-C virus (HCV) has infected an estimated 130 million people worldwide, most of whom are chronically infected. Infection is marked by both treatment- and non-treatment-related psychiatric symptoms. Symptoms associated with antiretroviral therapy, interferon-alpha (IFN-α), include acute confusional states, delirium, depression, irritability, and even mania. These psychiatric symptoms are further complicated by the high rate of substance abuse and comorbid HIV infection inherent to this population. Even in the absence of IFN-α therapy, comorbid depression, cognitive decline, and especially fatigue are common in patients suffering HCV. These comorbidities have significant effects on both treatments and outcomes, and thus are reviewed herein.


Articles with similar content:

A Review of Spasticity Treatments: Pharmacological and Interventional Approaches
Critical Reviews™ in Physical and Rehabilitation Medicine, Vol.25, 2013, issue 1-2
Eric Y. Chang, Daniela Alexandru, Sujin Lee, Tahseen Mozaffar, Daniel Yanni, Nilasha Ghosh
Exercise to Manage MS Fatigue: Counterintuitive Yet Effective
Critical Reviews™ in Physical and Rehabilitation Medicine, Vol.27, 2015, issue 2-4
A. V. Caprariello, K. M. Othonos, S. F. Kornfeld, Audrey L. Hicks
Physical Activity in the Treatment and Management of Fibromyalgia
Critical Reviews™ in Physical and Rehabilitation Medicine, Vol.17, 2005, issue 1
Kimberley A. Dawson, Peter M. Tiidus
Cholelithiasis and Cholecystitis
Journal of Long-Term Effects of Medical Implants, Vol.15, 2005, issue 3
Richard Edlich, Bruce D. Schirmer, Kathryne L. Winters
Bilateral Spontaneous Quadriceps Tendon Ruptures after Staged Bilateral Total Knee Arthroplasties: A Case Report
Journal of Long-Term Effects of Medical Implants, Vol.28, 2018, issue 1
Preston W. Grieco, Aditya V. Maheshwari, Marine Coste, Jared M. Newman, Ahmed M. Eldib , Neil V. Shah